Agnieszka Kluz

Agnieszka Kluz


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MZMarcin Zietek
Marcin Zietek
PTPawel Teterycz
Pawel Teterycz
JWJędrzej Wierzbicki
Jędrzej Wierzbicki
MJMichał Jankowski
Michał Jankowski
MLManuela Las-Jankowska
Manuela Las-Jankowska
Piotr RutkowskiPiotr Rutkowski
Piotr Rutkowski
Background: In melanoma treatment, an approach following positive sentinel lymph node biopsy (SLNB) has been recently deescalated from completion lymph node dissection (CLND) to active surveillance based on phase III trials data. In this study, we aim to evaluate treatment strategies in SLNB-positive melanoma patients in real-world practice. Methods: Five-hundred-fifty-seven melanoma SLNB-positive patients from seven comprehensive cancer centers treated between 2017 and 2021 were included. Kaplan–Meier methods and the Cox Proportional-Hazards Model were used for analysis. Results: The median follow-up was 25 months. Between 2017 and 2021, the percentage of patients undergoing CLND decreased (88–41%), while the use of adjuvant treatment increased (11–51%). The 3-year OS and RFS rates were 77.9% and 59.6%, respectively. Adjuvant therapy prolonged RFS (HR:0.69, p = 0.036)), but CLND did not (HR:1.22, p = 0.272). There were no statistically significant differences in OS for either adjuvant systemic treatment or CLND. Lower progression risk was also found, and time-dependent hazard ratios estimation in patients treated with systemic adjuvant therapy was confirmed (HR:0.20, p = 0.002 for BRAF inhibitors and HR:0.50, p = 0.015 for anti-PD-1 inhibitors). Conclusions: Treatment of SLNB-positive melanoma patients is constantly evolving, and the role of surgery is currently rather limited. Whether CLND has been performed or not, in a group of SLNB-positive patients, adjuvant systemic treatment should be offered to all eligible patients.

13 May 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KZKrystian Zukierski
Krystian Zukierski
WJWeronika Jarych
Weronika Jarych
KMKatarzyna Michalak
Katarzyna Michalak
MMMichał Mazur
Michał Mazur
KŻKatarzyna Żak
Katarzyna Żak
AKAgnieszka Kluz
Agnieszka Kluz
Introduction and aim: Breast cancer is the most frequently diagnosed malignant neoplasm among women in most countries worldwide and remains one of the leading causes of cancer-related mortality. Despite advances in early detection and treatment methods, breast cancer incidence continues to rise, particularly in highly developed countries. Preventive strategies, especially those emphasizing the promotion of physical activity, play a crucial role in breast cancer prevention by positively influencing hormonal regulation, reducing systemic inflammation, and enhancing metabolic functions. The aim of this study is to analyze the association between physical activity and breast cancer risk. Methods and materials: This comprehensive literature review utilized the PubMed and Google Scholar databases, focusing on studies published over the past 15 years from 2010 to 2025. The search strategy was designed to gather an extensive body of research examining the role of physical activity in the prevention of breast cancer. Key search terms employed included "breast cancer", "physical activity", "exercise" and “prevention”. The selected studies were thoroughly evaluated to ensure quality and rigor, with a focus on their relevance, methodological soundness, and overall significance. Results and conclusion: A comprehensive literature review confirms that regular physical activity reduces the risk of breast cancer by supporting metabolic, hormonal, and immune health in women, both pre- and postmenopausal, including carriers of genetic mutations. Physical activity also has therapeutic value following diagnosis, enhancing quality of life and reducing mortality rates.

14 April 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KŻKatarzyna Żak
Katarzyna Żak
KMKatarzyna Madyniak
Katarzyna Madyniak
HJHubert Jucha
Hubert Jucha
AKAgnieszka Kluz
Agnieszka Kluz
APAleksandra Pliszka
Aleksandra Pliszka
KMKatarzyna Michalak
Katarzyna Michalak
Apitherapy has been developed in recent years, providing treatments using honey and other bee products to combat various diseases. Honey and propolis contain bioactive compounds such as flavonoids and phenolic acids, minerals, vitamins, enzymes and many more which are responsible for numerous health-promoting features. [1] Among this benefits are anti-diabetic, cardioprotective, wound healing, antiviral, antimicrobal, anti-aging, immunomodulatory effects. The purpose of this review is to summarize and update the current information regarding the role of honey and propolis in health and diseases. Aim of the study This study reviews recent research on honey and propolis, highlighting their key healing compounds and clinical applications in treating various diseases. The study proposes directions for future research and highlights knowledge gaps. Materials and methods To evaluate studies on the therapeutic effects of honey and propolis, we conducted a comprehensive literature review using databases, including PubMed, Google Scholar, and ScienceDirect. The main keywords used in the search included: apitherapy, honey, propolis. Conclusions In conclusion, honey and propolis are emerging as promising therapeutical options, with evidence supporting their effectiveness in treating various health conditions (cardiovascular diseases, prediabetes, hypertension, infections, pain, and wound healing). Given their safety, efficacy, and inexpensiveness, they could be viable alternatives to conventional treatment. However, further research is crucial to better understand the active ingredients and mechanisms of action, ultimately guiding the development of effective therapies and clear clinical guidelines.

8 December 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AKAgnieszka Kluz
Agnieszka Kluz
KŻKatarzyna Żak
Katarzyna Żak
HJHubert Jucha
Hubert Jucha
MMMichał Mazur
Michał Mazur
APAleksandra Pliszka
Aleksandra Pliszka
KMKatarzyna Madyniak
Katarzyna Madyniak
Introduction and purposeUltramarathon running has gained popularity in recent years, yet it presents unique physiological challenges. One of the increasingly recognized complications is acute kidney injury (AKI), which may result from extreme exertion. This review aims to summarize current knowledge on AKI risk in ultrarunners and identify key contributing factors. Material and methodA narrative review of literature was conducted using PubMed, Scopus and Google Scholar databases. Keywords included: "ultramarathon", "acute kidney injury", "rhabdomyolysis", "NSAIDs", and "hydration". Peer-reviewed articles from 2000 to 2024 were included. Studies were selected based on their relevance to AKI mechanisms and prevalence in endurance athletes. Data were synthesized qualitatively. ResultsAKI in ultramarathon runners is multifactorial. Key contributors include dehydration, exercise-associated hyponatremia (EAH), exertional rhabdomyolysis, NSAID use, and gastrointestinal disorders impairing hydration and nutrition. While transient renal dysfunction is relatively common, severe AKI requiring intervention is rare. Biomarkers such as cystatin C and NGAL may provide more accurate diagnosis than creatinine alone. NSAIDs and EAH increase the risk of coexisting rhabdomyolysis, complicating clinical management. ConclusionsAlthough the long-term health benefits of ultrarunning may outweigh the risks, AKI remains a clinically relevant concern. Medical supervision, adequate hydration strategies, and education on NSAID use are essential to reduce kidney-related complications in ultra-endurance athletes.

23 April 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
MMMichał Mazur
Michał Mazur
KŻKatarzyna Żak
Katarzyna Żak
KMKatarzyna Michalak
Katarzyna Michalak
KZKrystian Zukierski
Krystian Zukierski
WJWeronika Jarych
Weronika Jarych
AKAgnieszka Kluz
Agnieszka Kluz
Schizophrenia is a complex psychiatric disorder often resistant to dopamine-targeting antipsychotics. Cobenfy, a combination of xanomeline and trospium chloride, offers a novel approach by modulating muscarinic receptors while minimizing side effects. This review evaluates its efficacy and safety, particularly in treatment-resistant cases. Clinical trials show significant reductions in both positive and negative symptoms, positioning Cobenfy as a promising alternative.

26 November 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
KMKatarzyna Michalak
Katarzyna Michalak
KZKrystian Zukierski
Krystian Zukierski
MMMichał Mazur
Michał Mazur
KŻKatarzyna Żak
Katarzyna Żak
HJHubert Jucha
Hubert Jucha
AKAgnieszka Kluz
Agnieszka Kluz
Introduction and Aim: Crohn's Disease (CD) is a chronic inflammatory bowel disease (IBD) characterized by periods of remission and relapse. The influence of lifestyle, particularly physical activity, on the course of IBD is increasingly recognized. This study aims to examine the impact of physical activity on the clinical course of Crohn's disease and the development of associated complications. Methods and Materials: This research will involve a systematic review of the literature published between 2010 and 2025. Relevant studies will be identified by searching electronic databases including PubMed and Google Scholar databases. The search strategy will utilize a combination of keywords related to Crohn's disease, physical activity, exercise, and osteopenia. Studies published in English and Polish that examine the effect of exercise interventions on adult CD patients will be included. Studies evaluating the impact of exercise on disease activity, quality of life, bone mineral density, and other relevant outcomes will be considered. The methodological quality of the included studies will be assessed using appropriate tools. Data extraction and synthesis will be performed following established guidelines for systematic reviews. Results and Conclusion: A comprehensive studies review suggests that physical activity can be a valuable tool in managing Crohn's Disease and preventing complications such as osteopenia. Exercise appears to offer benefits for bone health, mental well-being and overall quality of life of patients with CD. It’s important to note that further research is needed to determine the optimal type, intensity, and duration of exercise for individuals with CD, as well as to identify strategies to promote adherence to exercise programs.